Ibio Inc (IBIO) 1.09 $IBIO
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - Fri Nov 14, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 103.71 (+3.27), IBIO: 1.09 (+0.03), ARIA: 6.24 (+0.20), MNKD: 6.60 (+0.34), CELG: 106.78 (+2.42)
Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Thu Nov 13, 1:35PM CST
Morgan & Morgan reminds investors that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.09 (+0.03)
IBIO SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Nov 12, 11:27AM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company" (NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.09 (+0.03)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:18AM CST
ANV: 2.04 (+0.37), KEP: 20.20 (-0.14), RADA: 2.54 (+0.24), SEAS: 17.06 (+0.12), HPJ: 6.09 (+0.02), PLUG: 4.04 (+0.32), SUPN: 9.07 (+0.81), NBG: 2.25 (+0.07), GV: 2.06 (+0.03), OXGN: 1.78 (-0.05), NOAH: 17.05 (+0.52), FOSL: 108.02 (+0.60), AEO: 13.26 (-0.08), IBIO: 1.09 (+0.03), MTOR: 13.78 (-0.20), MLNX: 43.00 (+0.51), SUSQ: 13.10 (+0.06)
SECURITIES ALERT: Rosen Law Firm Reminds iBio, Inc. Investors of Important Deadline in Class Action Filed by the Firm - IBIO
GlobeNewswire - Tue Nov 11, 9:34AM CST
Rosen Law Firm reminds purchasers of iBio, Inc. common stock (NYSE:IBIO) between October 13, 2014 and October 23, 2014, of the important December 23, 2014 lead plaintiff deadline in the class action filed by the firm.
IBIO: 1.09 (+0.03)
Hagens Berman Reminds Investors of the Upcoming Lead Plaintiff Deadline of December 23, 2014 in the Class Action Lawsuit Against iBio, Inc. (NYSE MKT: IBIO)
GlobeNewswire - Tue Nov 11, 7:38AM CST
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against iBio, Inc. (NYSE MKT:IBIO) ("iBio" or "the Company) The suit is pending in U.S. District Court for the District of Delaware and investors have until December 23, 2014 to move for lead plaintiff.
IBIO: 1.09 (+0.03)
iBio Grants Caliber License for Production of Antibodies Targeting Ebola
Marketwired - Mon Nov 10, 7:31AM CST
iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch(TM) platform for production by Caliber of antibodies that target the Ebola virus.
IBIO: 1.09 (+0.03)
Fear In The Time Of Ebola Stocks: Debunking The iBio Bear Thesis
Joel Badeaux - at Seeking Alpha - Tue Nov 04, 3:09PM CST
IBIO: 1.09 (+0.03)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in iBio, Inc. (IBIO) to Contact the Firm
Marketwired - Sat Nov 01, 8:30AM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company" (NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO.
IBIO: 1.09 (+0.03)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 31, 2:15PM CDT
Morgan & Morgan announces that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company" (NYSE:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.09 (+0.03)
Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action
GlobeNewswire - Wed Oct 29, 5:27PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of iBio, Inc. (NYSE:IBIO) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of Delaware. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between October 13, 2014 and October 23, 2014. iBio is a biotechnology company that focuses on the commercialization of proprietary plant-based protein expression technologies in the United States and internationally.
IBIO: 1.09 (+0.03)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO
GlobeNewswire - Wed Oct 29, 12:57PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of purchasers of iBio, Inc. ("iBio" or the "Company" (NYSE:IBIO) common stock during the period between October 13, 2014 and October 23, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 23, 2014 to seek appointment as lead plaintiff.
IBIO: 1.09 (+0.03)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Oct 29, 10:45AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company" (NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.09 (+0.03)
Market Maker Surveillance Report. SIRI, KEG, IBIO, GRNH, EGXKP, FB, Highest Net Sell Volume and Negative Price Friction For Tuesday, October 28th 2014
M2 - Wed Oct 29, 4:44AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4520 companies with "abnormal" market making, 3969 companies with positive Friction Factors and 1393 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sirius XM Radio Inc (NASDAQ:SIRI), Key Energy Services Inc (NYSE:KEG), Ibio Inc (NYSE:IBIO), Greengro Technologies Inc (OTC:GRNH), (OTC:EGXKP), Facebook Inc (NASDAQ:FB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
FB: 74.34 (+0.10), KEG: 2.41 (-0.08), IBIO: 1.09 (+0.03), SIRI: 3.56 (+0.04)
Harwood Feffer LLP Announces Investigation of iBio, Inc.
PR Newswire - Tue Oct 28, 7:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of iBio, Inc. ("iBio" or the "Company" (NYSE: IBIO), concerning whether the board has breached its fiduciary duties to shareholders.
IBIO: 1.09 (+0.03)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In iBio, Inc. (IBIO) To Contact The Firm
PR Newswire - Tue Oct 28, 4:05PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company" (NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO.
IBIO: 1.09 (+0.03)
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - Fri Nov 14, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 103.71 (+3.27), IBIO: 1.09 (+0.03), ARIA: 6.24 (+0.20), MNKD: 6.60 (+0.34), CELG: 106.78 (+2.42)
Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Thu Nov 13, 1:35PM CST
Morgan & Morgan reminds investors that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.09 (+0.03)
IBIO SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Nov 12, 11:27AM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.09 (+0.03)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:18AM CST
ANV: 2.04 (+0.37), KEP: 20.20 (-0.14), RADA: 2.54 (+0.24), SEAS: 17.06 (+0.12), HPJ: 6.09 (+0.02), PLUG: 4.04 (+0.32), SUPN: 9.07 (+0.81), NBG: 2.25 (+0.07), GV: 2.06 (+0.03), OXGN: 1.78 (-0.05), NOAH: 17.05 (+0.52), FOSL: 108.02 (+0.60), AEO: 13.26 (-0.08), IBIO: 1.09 (+0.03), MTOR: 13.78 (-0.20), MLNX: 43.00 (+0.51), SUSQ: 13.10 (+0.06)
SECURITIES ALERT: Rosen Law Firm Reminds iBio, Inc. Investors of Important Deadline in Class Action Filed by the Firm - IBIO
GlobeNewswire - Tue Nov 11, 9:34AM CST
Rosen Law Firm reminds purchasers of iBio, Inc. common stock (NYSE:IBIO) between October 13, 2014 and October 23, 2014, of the important December 23, 2014 lead plaintiff deadline in the class action filed by the firm.
IBIO: 1.09 (+0.03)
Hagens Berman Reminds Investors of the Upcoming Lead Plaintiff Deadline of December 23, 2014 in the Class Action Lawsuit Against iBio, Inc. (NYSE MKT: IBIO)
GlobeNewswire - Tue Nov 11, 7:38AM CST
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against iBio, Inc. (NYSE MKT:IBIO) ("iBio" or "the Company) The suit is pending in U.S. District Court for the District of Delaware and investors have until December 23, 2014 to move for lead plaintiff.
IBIO: 1.09 (+0.03)
iBio Grants Caliber License for Production of Antibodies Targeting Ebola
Marketwired - Mon Nov 10, 7:31AM CST
iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch(TM) platform for production by Caliber of antibodies that target the Ebola virus.
IBIO: 1.09 (+0.03)
Fear In The Time Of Ebola Stocks: Debunking The iBio Bear Thesis
Joel Badeaux - at Seeking Alpha - Tue Nov 04, 3:09PM CST
IBIO: 1.09 (+0.03)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in iBio, Inc. (IBIO) to Contact the Firm
Marketwired - Sat Nov 01, 8:30AM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO. IBIO: 1.09 (+0.03)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 31, 2:15PM CDT
Morgan & Morgan announces that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.09 (+0.03)
Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action
GlobeNewswire - Wed Oct 29, 5:27PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of iBio, Inc. (NYSE:IBIO) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of Delaware. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between October 13, 2014 and October 23, 2014. iBio is a biotechnology company that focuses on the commercialization of proprietary plant-based protein expression technologies in the United States and internationally.
IBIO: 1.09 (+0.03)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO
GlobeNewswire - Wed Oct 29, 12:57PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of purchasers of iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) common stock during the period between October 13, 2014 and October 23, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 23, 2014 to seek appointment as lead plaintiff. IBIO: 1.09 (+0.03)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Oct 29, 10:45AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.09 (+0.03)
Market Maker Surveillance Report. SIRI, KEG, IBIO, GRNH, EGXKP, FB, Highest Net Sell Volume and Negative Price Friction For Tuesday, October 28th 2014
M2 - Wed Oct 29, 4:44AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4520 companies with "abnormal" market making, 3969 companies with positive Friction Factors and 1393 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sirius XM Radio Inc (NASDAQ:SIRI), Key Energy Services Inc (NYSE:KEG), Ibio Inc (NYSE:IBIO), Greengro Technologies Inc (OTC:GRNH), (OTC:EGXKP), Facebook Inc (NASDAQ:FB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
FB: 74.34 (+0.10), KEG: 2.41 (-0.08), IBIO: 1.09 (+0.03), SIRI: 3.56 (+0.04)
Harwood Feffer LLP Announces Investigation of iBio, Inc.
PR Newswire - Tue Oct 28, 7:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO), concerning whether the board has breached its fiduciary duties to shareholders. IBIO: 1.09 (+0.03)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In iBio, Inc. (IBIO) To Contact The Firm
PR Newswire - Tue Oct 28, 4:05PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO. IBIO: 1.09 (+0.03)
